 Mahindra Logistics Ltd reports consolidated loss of Rs. 10.35 crores in Q2FY26
Mahindra Logistics Ltd reports consolidated loss of Rs. 10.35 crores in Q2FY26 Indian Oil Corporation Ltd consolidated Q2 FY2025-26 net profit climbs to Rs. 7817.55 crores
Indian Oil Corporation Ltd consolidated Q2 FY2025-26 net profit climbs to Rs. 7817.55 crores Jubilant Ingrevia Ltd posts Rs. 69.47 crores consolidated PAT in Q2FY26
Jubilant Ingrevia Ltd posts Rs. 69.47 crores consolidated PAT in Q2FY26 Raghav Productivity Enhancers Ltd Q2FY26 consolidated profit at Rs. 13.84 crores
Raghav Productivity Enhancers Ltd Q2FY26 consolidated profit at Rs. 13.84 crores Canara Robeco Asset Management Company Ltd Q2FY26 PAT drops to Rs. 48.71 crores
Canara Robeco Asset Management Company Ltd Q2FY26 PAT drops to Rs. 48.71 crores 
              Jupiter Bioscience Ltd has announced that the Board of Directors of the Company at its meeting held on May 28, 2007, has allotted 31,77,500 Equity Share Warrants to M/s. Ranbaxy Laboratories Ltd on a preferential basis representing approximately 14.91% of the expanded issued Share Capital of the Company at a price of Rs 147/- per Equity Share Warrant.
The said Equity Share Warrants convertible into Equity shares within a period of 18 months from the date of allotment OR at the time of exercise of option by M/s. Ranbaxy Laboratories Ltd which ever is earlier. The Company has already received 20% of the total consideration up front.
The stock was trading at Rs.179.75, down by Rs.5.85 or 3.15%. The stock hit an intraday high of Rs.188.45 and low of Rs.178.65. The total traded quantity was 285667 compared to 2 week average of 326585.